Best Ancillary Cannabis Stocks
Updated March 2026Top ancillary cannabis stocks ranked by market cap. Companies providing services, technology, and infrastructure to the cannabis industry.
Ancillary cannabis companies provide the picks and shovels of the marijuana industry — the technology platforms, cultivation equipment, packaging solutions, consulting services, and other infrastructure that plant-touching operators depend on. These companies do not directly handle cannabis, which gives them significant structural advantages: they can access traditional banking, list on major exchanges, deduct normal business expenses (no 280E), and sell to customers across all legal markets without needing state-by-state licenses.
The ancillary cannabis sector includes a diverse range of business models. Software companies provide seed-to-sale tracking, point-of-sale systems, and compliance platforms. Equipment companies manufacture grow lights, extraction machines, and testing devices. Real estate companies own and lease properties to cannabis operators. Marketing and consulting firms help operators navigate regulatory complexities. This diversity means ancillary stocks behave differently from one another and from plant-touching cannabis companies.
The ranking below organizes ancillary cannabis stocks by market capitalization. Because ancillary companies are not subject to the same regulatory and financial constraints as MSOs and LPs, they often trade at higher valuation multiples, reflecting their lower risk profiles and more conventional business structures.
Best Ancillary Cannabis Stocks — Full Rankings
12 stocks · Ranked by market cap
| # | Ticker | Name | Price | Change | Market Cap | Revenue | Margin | P/S | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SMG | Scotts Miracle-Gro | $60.96 | +0.96% | $3.54B | $3.35B | 25.0% | 1.06x | $3.54B |
| 2 | TPB | Turning Point Brands | $90.62 | +0.69% | $1.73B | $463.1M | 55.9% | 3.75x | $1.73B |
| 3 | KERN | Akerna Corp | $6.27 | +24.64% | $376.3M | $6.8M | 402.0% | 55.05x | $376.3M |
| 4 | LFLY | Leafly Holdings | $135.50 | +17.98% | $271.0M | $34.6M | 90.2% | 7.82x | $271.0M |
| 5 | AGFY | Agrify Corp | $47.12 | +4.71% | $94.2M | $15.4M | 75.5% | 6.12x | $94.2M |
| 6 | MAPS | WM Technology (Weedmaps) | $0.68 | -7.27% | $73.0M | $174.7M | 94.9% | 0.42x | $73.0M |
| 7 | FORA | Forian Inc | $2.05 | -0.97% | $63.7M | $28.1M | 51.6% | 2.27x | $63.7M |
| 8 | GRWG | GrowGeneration | $1.06 | -2.75% | $63.4M | $161.4M | 27.2% | 0.39x | $63.4M |
| 9 | GRAMF | TPCO Holding (The Parent Company) | $0.16 | -12.99% | $45.7M | $0 | — | — | $45.7M |
| 10 | HYFM | Hydrofarm Holdings | $1.19 | -6.30% | $5.6M | $146.4M | 11.6% | 0.04x | $5.6M |
| 11 | GNLN | Greenlane Holdings | $0.82 | -1.84% | $4.1M | $4.7M | -692.4% | 0.89x | $4.1M |
| 12 | FNNZF | FinCanna Capital | $0.00 | +38.10% | $545.2K | $0 | — | — | $545.2K |
Top 3 Spotlight
Scotts Miracle-Gro
Scotts Miracle-Gro ranks #1 in the best ancillary cannabis stocks category with a share price of $60.96 and a market capitalization of $3.54B. The company operates in the Ancillary sector and is listed on the NYSE. With trailing twelve-month revenue of $3.35B and a gross margin of 25.0%, SMG represents the top-ranked stock in this category based on market cap.
Turning Point Brands
Turning Point Brands ranks #2 in the best ancillary cannabis stocks category with a share price of $90.62 and a market capitalization of $1.73B. The company operates in the Ancillary sector and is listed on the NYSE. With trailing twelve-month revenue of $463.1M and a gross margin of 55.9%, TPB represents the second-ranked stock in this category based on market cap.
Akerna Corp
Akerna Corp ranks #3 in the best ancillary cannabis stocks category with a share price of $6.27 and a market capitalization of $376.3M. The company operates in the Ancillary sector and is listed on the NASDAQ. With trailing twelve-month revenue of $6.8M and a gross margin of 402.0%, KERN represents the third-ranked stock in this category based on market cap.
Methodology
Stocks are filtered to include only companies classified as Ancillary (non-plant-touching) cannabis businesses and ranked in descending order by market capitalization. Data is sourced from company filings, exchange feeds, and financial data providers. Rankings update automatically as new data becomes available. All financial figures are based on trailing twelve-month (TTM) data unless otherwise noted. The current ranking includes 12 qualifying stocks out of 100 total cannabis companies tracked by Cannabismarketcap.
Key Observations
The top-ranked stock in the best ancillary cannabis stocks category is SMG (Scotts Miracle-Gro) with a market cap of $3.54B. The stock trades at $60.96 per share with a market capitalization of $3.54B. In second place is TPB ($1.73B), followed by KERN ($376.3M) in third.
Across all 12 qualifying stocks, the average share price is $28.87 and the average market capitalization is $522.5M. The combined trailing twelve-month revenue of all companies in this category is $4.39B. The average gross margin among companies with positive margins is 92.7%. The average price-to-sales ratio is 7.78x.
The most represented sector in this category is Ancillary with 12 out of 12 companies (100%). Among the ranked stocks, 6 are trading higher today while 6 are trading lower. Investors should use these observations as a starting point for further research rather than as the basis for trading decisions.
Investment Considerations
When evaluating stocks in the best ancillary cannabis stocks category, consider looking beyond the primary ranking metric to build a holistic view of each company. A stock that ranks well by market cap may have weaknesses in other areas — such as high debt, poor margins, or slowing growth — that the ranking alone does not capture. Cross-reference this list with other Cannabismarketcap category pages and the screener tool to identify stocks that score well across multiple dimensions.
Position sizing is particularly important in cannabis. The sector is inherently volatile, and even the strongest companies can experience 30-50% drawdowns during sector-wide sell-offs triggered by legislative disappointments or broader market risk-off events. Most financial advisors suggest limiting total cannabis exposure to 5-15% of your portfolio, and individual positions to 1-3% depending on your risk tolerance and conviction level.
Dollar-cost averaging (DCA) is a widely recommended approach for building cannabis stock positions over time. Rather than investing your entire allocation at a single price point, spreading purchases across weeks or months can reduce the impact of short-term volatility and lower your average cost basis if prices decline after your initial purchase. This strategy is particularly relevant for the stocks in this category given the sector's history of sharp and sometimes prolonged drawdowns.
Risk Factors
Risk Warning
Ancillary cannabis companies depend on the health of their plant-touching customers. If MSOs and LPs cut spending due to financial pressure, ancillary companies see reduced demand. Many ancillary businesses face competition from general-purpose alternatives — a cannabis company might choose a mainstream POS system over a cannabis-specific one if regulations allow it. Some ancillary companies have diversified into non-cannabis markets, which can be positive (reduced concentration risk) but may also dilute the pure-play cannabis thesis that attracted investors initially. Customer concentration is a common risk, with some ancillary companies deriving a large percentage of revenue from a small number of cannabis operators.
Compare These Stocks
Head-to-head comparisons between top-ranked stocks in this category.
Frequently Asked Questions
What are ancillary cannabis companies?
Ancillary cannabis companies are businesses that support the cannabis industry without directly cultivating, processing, or selling cannabis products. They are sometimes called 'non-plant-touching' companies. Examples include technology platforms (seed-to-sale tracking, compliance software), equipment manufacturers (grow lights, extraction machines), testing laboratories, packaging companies, consulting firms, staffing agencies, and marketing companies. Because they do not handle cannabis directly, they avoid many of the legal and financial restrictions faced by plant-touching operators.
Why do investors choose ancillary stocks over MSOs or LPs?
Ancillary stocks offer cannabis sector exposure with lower regulatory risk. Key advantages include listing on major exchanges (NASDAQ, NYSE) which provides better liquidity and institutional access, normal tax treatment without 280E penalties, access to traditional banking and lending, and the ability to operate across all legal markets without state-specific cannabis licenses. For risk-averse investors who believe in the long-term growth of the cannabis industry but want to avoid the direct regulatory exposure of plant-touching companies, ancillary stocks provide a compelling alternative.
What risks are specific to ancillary cannabis stocks?
The primary risk is customer dependency on a volatile industry. If cannabis operators face financial distress, they cut spending on ancillary services and technology. Ancillary companies also face the risk of disintermediation — as the cannabis industry matures, plant-touching companies may bring previously outsourced functions in-house or switch to cheaper, non-cannabis-specific providers. Additionally, some ancillary companies have struggled to achieve profitability despite the promise of the cannabis opportunity, as the total addressable market for niche cannabis services may be smaller than initially projected.
Do ancillary cannabis stocks benefit from legalization catalysts?
Yes, but typically with less dramatic price movements than plant-touching companies. Federal legalization or major regulatory reform would expand the legal cannabis market, increasing demand for ancillary products and services. However, ancillary stocks already trade on major exchanges and have access to traditional banking, so they benefit less from the removal of those specific barriers. The main positive catalyst for ancillary companies is overall industry growth — more legal cannabis sales means more demand for the tools, technology, and services that support those sales.
More on Cannabismarketcap
Disclaimer: The information on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis stocks are highly speculative and carry significant risk of loss, including the potential loss of your entire investment. Past performance is not indicative of future results. The rankings and data presented are based on publicly available financial information and may contain errors or omissions. Always do your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap is not a registered investment advisor, broker-dealer, or financial planner.